The reduction in price target by HC Wainwright & Co. could lead to a negative short-term sentiment among investors, potentially causing a decrease in Annovis Bio's stock price. However, the maintenance of a Buy rating indicates a positive outlook on the company's fundamentals, which might mitigate some of the negative impact.